Royalty Pharma Says It Announces Pricing Of $2.0 Billion Of Senior Unsecured Notes
Sept 2 (Reuters) - Royalty Pharma PLC RPRX.O:
ROYALTY PHARMA ANNOUNCES PRICING OF $2.0 BILLION OF SENIOR UNSECURED NOTES
ROYALTY PHARMA - $600 MILLION OF 4.450% NOTES DUE 2031
ROYALTY PHARMA - PRICES $500 MILLION OF 5.950% NOTES DUE 2055
ROYALTY PHARMA PLC - PRICES $900 MILLION NOTES DUE 2035 AT 5.200%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Intel Foundry Gains ‘High-Profile’ Customer, Tesla Becomes First Major Customer for 14A Technology

Anthropic Eclipses OpenAI in Secondary Market as Valuation Hits $1 Trillion Milestone, Is the AI Market Overheating Now?

Robinhood Stock Predictions: Can HOOD Reach the $1,000 Milestone?

Tesla Officially Announces. Third-Generation Humanoid Robot to Debut Mid-Year, Mass Production to Start in Third Quarter

Intel Better-Than-Expected Earnings Released, Stock Surges 20% After-Hours, AI Computing Power Enters CPU Moment?

Tradingkey








